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Objective: Upper gastrointestinal (GI) bleeding is a serious complication that sometimes occurs after percutaneous 
radiologic gastrostomy (PRG). We evaluated the incidence of bleeding complications after a PRG and its management 
including transcatheter arterial embolization (TAE). 
Materials and Methods: We retrospectively reviewed 574 patients who underwent PRG in our institution between 2000 and 
2010. Eight patients (1.4%) had symptoms or signs of upper GI bleeding after PRG.
Results: The initial presentation was hematemesis (n = 3), melena (n = 2), hematochezia (n = 2) and bloody drainage 
through the gastrostomy tube (n = 1). The time interval between PRG placement and detection of bleeding ranged from 
immediately after to 3 days later (mean: 28 hours). The mean decrease in hemoglobin concentration was 3.69 g/dL (range, 
0.9 to 6.8 g/dL). In three patients, bleeding was controlled by transfusion (n = 2) or compression of the gastrostomy site 
(n = 1). The remaining five patients underwent an angiography because bleeding could not be controlled by transfusion 
only. In one patient, the bleeding focus was not evident on angiography or endoscopy, and wedge resection including the 
tube insertion site was performed for hemostasis. The other four patients underwent prophylactic (n = 1) or therapeutic (n 
= 3) TAEs. In three patients, successful hemostasis was achieved by TAE, whereas the remaining one patient underwent 
exploration due to persistent bleeding despite TAE.
Conclusion: We observed an incidence of upper GI bleeding complicating the PRG of 1.4%. TAE following conservative 
management appears to be safe and effective for hemostasis.
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Gastrostomy is a well-established procedure for long-term 
nutritional support or gastric decompression in patients 
incapable of oral intake due to various disorders (1, 2). 
Gastrostomy may be performed surgically or percutaneously, 
under either endoscopic or fluoroscopic guidance (1). 
Percutaneous radiologic or endoscopic gastrostomy (PRG or 
PEG) is less invasive and has lower complication rates than 
surgical methods. The incidence of major complications 
after PRG or PEG has been found to range from 0 to 6% (3-5). 
Upper gastrointestinal (GI) bleeding complicating 
gastrostomy is rare, but may be catastrophic when it 
occurs (6-11). Most patients who experience gastric 
bleeding have undergone surgical gastrostomy or PEG (7-
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11), with few reports focusing on bleeding complications 
after PRG. Furthermore, even less is known about the 
use of transcatheter arterial embolization (TAE) to treat 
gastrostomy-related upper GI bleeding (8, 10). We therefore 
assessed the incidence of bleeding complications after PRG 
and their management, including TAE.
MATERIALS AND METHODS
Patients
From September 2000 to September 2010, 574 patients 
underwent PRG at our institution. The gastrostomy was 
most commonly indicated in patients with swallowing 
difficulties due to neurological disorders or head and neck 
malignancy. Further indications were in those patients 
who need additional nutritional support due to chronic 
illness or intestinal malabsorption and less commonly 
in those patients who require gastric decompression. 
Contraindications included interposition of the colon and 
the liver between the stomach and the anterior abdominal 
wall, previous gastric surgery, presence of ascites, and 
severe uncontrollable coagulopathy. Screening for bleeding 
tendency was performed before PRG procedure and 
acceptable coagulation parameters at our institution were 
a prothrombin time over 60 percent and a platelet count 
exceeding 50000 i.u. Although ceasing any anticoagulant 
medications at the time of procedure was strongly 
recommended, correction of coagulopathy was enough in 
those patients who should continue their medications.
We searched the records for patients who had symptoms 
or signs of upper GI bleeding after PRG, including 
hematemesis, melena, hematochezia or bloody drainage 
from the gastrostomy tube (11). Of these 574 patients, 8 
(1.4%) had episodes of upper GI bleeding. They included 
6 men and 2 women, ranging in age from 32-87 years 
(mean age, 69 years). PRG was performed for head and 
neck malignancy in 3 patients, cerebral infarction in 2, and 
neuromuscular disorder, vascular dementia with dysphagia, 
nutritional support after surgical repair of aortic dissection 
in 1 patient each. 
Technique
Gastrostomy
The stomach was inflated with about 300-400 mL of air, 
using a previously inserted nasogastric tube or a 5-F Cobra 
catheter (Cook, Bloomington, IN, USA) previously inserted 
under fluoroscopic guidance. A puncture site equidistant 
from the greater and lesser curvatures of the stomach 
was selected at the distal gastric body, with one anchor 
(Cope gastrointestinal suture anchor sets; Cook) used for 
gastropexy. Interposition of the left hepatic lobe and the 
colon were carefully avoided using ultrasound and an air 
enema. After local anesthesia with 1% lidocaine, a 17-gauge 
needle with a preloaded anchor or a 21-gauge Chiba 
needle was inserted into the stomach through the skin 
incision site, and the intragastric position of the needle 
was confirmed by contrast injection. The Chiba-needle was 
then exchanged for a 6-Fr Neff catheter (Cook), and an 
anchor was deployed into the stomach lumen through the 
Neff catheter using a 0.035-inch superstiff guide wire for 
the gastropexy. When the stomach and abdominal wall were 
approximated, the tract was dilated over the guide-wire to 
enable placement of a 14-Fr diameter loop catheter (Cook), 
followed by injection of contrast material through the 
catheter to confirm its location.
TAE (Transcatheter arterial embolization)
A 5-Fr end-hole catheter was introduced over a 0.035-
inch guide-wire (Terumo; Radifocus, Tokyo, Japan) via the 
right femoral artery. Superior mesenteric, common hepatic 
and left gastric angiograms were performed in all patients. 
If there was evidence of active bleeding on the angiogram, 
defined as extravasation of contrast medium or the presence 
of a pseudoaneurysm (12), TAE was performed using a 
microcatheter by one of two interventional radiologists 
with 12-15 years of experience. Embolic materials included 
gelfoam slurry, microcoils, or N-butyl cyanoacrylate (NBCA). 
After TAE, a completion angiogram was obtained to confirm 
the cessation of bleeding or occlusion of the target arteries. 
Follow-up
Demographic data, initial presentation, time interval 
between PRG placement and detection of bleeding, possible 
causes of bleeding, administration of anticoagulants, 
decrease in hemoglobin (Hb) level, management of 
bleeding, and clinical outcomes were recorded for all eight 
patients by review of their electronic medical records, 
radiologic methods (angiography, CT, tubography), and 
endoscopic findings. 
RESULTS
Of the eight patients, three initially presented with Korean J Radiol 13(2), Mar/Apr 2012 kjronline.org 176
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hematemesis, followed by two with melena, two with 
hematochezia and one with bloody drainage through the 
gastrostomy tube. The time interval between PRG placement 
and detection of bleeding ranged from immediately after 
to 3 days later (mean, 27.8 h), with bleeding within 
24 hours observed in five patients. Seven patients 
experienced bleeding after their initial PRG, with one (No. 
6) experiencing PRG after PEG failure. The eighth patient 
(No. 4) experienced bleeding after reinsertion of the PRG 
tube following self-removal of a previously inserted tube. Of 
574 patients, 56 (9.8%) took anticoagulant medications at 
the time of the PRG procedure, and 2 of 56 patients (3.6%, 
No. 5, 8) on anticoagulants had bleeding complications. 
There was no significant difference in the incidence of 
bleeding complications between the two groups with and 
without anticoagulants (p = 0.179, Chi-square test using 
SPSS). Two patients (No. 5, 8) with cerebral infarction and 
one (No. 2) with a covered stent for a common carotid 
artery pseudoaneurysm (due to radiation therapy for 
nasopharyngeal cancer) had received anticoagulant therapy, 
and the patient with the covered stent stopped this 
medication one week before PRG. The mean decrease in Hb 
concentration was 3.69 g/dL (range, 0.9 to 6.8 g/dL).
Of the eight patients with bleeding complications, seven 
were given blood transfusions as an initial therapy (Table 
1), with two recovering after transfusion. The one patient 
(No. 8) who did not require a blood transfusion had a small 
amount of bloody drainage immediately after the PRG, 
which stopped after compression of the gastrostomy site. 
He had been taking aspirin and warfarin for the treatment 
of a cerebral infarction at the time of the procedure. 
Five patients required endoscopy as well as angiography 
as the next step in conservative management. Of the 
five patients who underwent angiography, two (No. 1, 5) 
showed no bleeding focus. One (No. 1) with massive GI 
bleeding and hypotension underwent prophylactic TAE of 
both gastric and right gastroepiploic arteries with gelfoam 
slurry, resulting in successful hemostasis. A subsequent 
endoscopy demonstrated hemorrhagic gastritis, which was 
regarded as resulting from irritation by the tube. No further 
bleeding was seen on endoscopy. The other patient (No. 5) 
showed substantial volumes of fresh blood and blood clots 
without demonstration of a bleeding focus on an endoscopy 
performed 12 hours after undergoing an angiography. 
Two days later, this patient underwent wedge resection 
including the tube insertion site for bleeding control. The 
tube insertion site was clear and a pathologic examination 
showed angiodysplasia in the resected stomach. 
Of the five patients who underwent angiography, three 
(No. 2-4) showed contrast extravasation. One (No. 2) who 
underwent covered stent insertion for a carotid artery 
pseudoaneurysm two weeks before PRG had an active 
bleeding focus in a branch of the right gastroepiploic 
artery, as well as multiple mycotic pseudoaneurysms in 
branches of the superior mesenteric artery, probably due 
to septic emboli (Fig. 1). TAE with NBCA was performed 
after selection of the bleeding focus at the common 
hepatic artery level. Another patient (No. 3) showed active 
bleeding from a branch of the short gastric artery. Because 
superselection of the branch was impossible, TAE with 
gelfoam slurry and microcoils was performed at the origin 
of the branch from the short gastric artery. A subsequent 
endoscopy showed no active bleeding after embolization. 
The third patient (No. 4), who had undergone surgical 
repair from an aortic dissection, showed an active bleeding 
focus at the tube insertion site on endoscopy. After 
tube removal, epinephrine and fibrin glue were injected 
with hemoclipping endoscopically, but bleeding was not 
controlled. A subsequent angiography showed an active 
bleeding focus at the greater curvature of the stomach (Fig. 
2). It was impossible to advance a microcatheter directly 
into the bleeding site due to a very tortuous course. TAE 
with gelfoam slurry and microcoils was performed at the 
proximal part of the right gastroepiploic artery. While 
post-TAE angiogram showed no further bleeding, bloody 
L-tube irrigation lasted and an emergency exploration 
was performed. The surgeons observed a tear of the right 
gastroepiploic artery, which was subsequently ligated. 
Although bleeding control was achieved, this patient died 
five weeks later due to surgical wound problems and sepsis. 
 
DISCUSSION
We found that the incidence of complications from 
upper GI bleeding after PRG was 1.4% (8/574) and that 
the incidence of major bleeding complications requiring 
transfusion was 1.2% (7/574). In comparison, other 
studies have reported that the incidence of major bleeding 
complications after percutaneous radiologic gastrostomy 
or gastroenterostomy was 0.7-3.0% (6, 7, 13), including 
1 of 130 patients (0.7%) with major gastric hemorrhage 
complicating the percutaneous transgastric jejunostomy (7), 
5 of 158 (3%) with major GI bleeding after percutaneous 
radiologic gastrostomy or gastroenterostomy (6), and 4 of Korean J Radiol 13(2), Mar/Apr 2012 kjronline.org 177
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216 (1.9%) with major bleeding after PRG with the one-
anchor technique of gastropexy (13). Similar incidences of 
bleeding complications have been reported after PEG (11, 
14-18), including in 2 of 314 (0.6%) (15) and 2 of 232 
(0.9%) patients (14) with major bleeding after installing 
PEG, and in 17 of 338 (4.1%) with episodes of upper GI 
bleeding after the PEG installation, including 14 with minor 
bleeding who did not require transfusions (11). Following 
surgical gastrostomy, major gastric hemorrhage requiring 
transfusion was observed in 4 of 424 (0.9%) and in 2 of 
Fig. 1. Thirty two-year-old male patient with nasopharyngeal cancer (patient No. 2). 
A. Superior mesenteric angiogram shows extravasation from branch of right gastroepiploic artery (arrows) adjacent to tube. Pseudoaneurysm 
(arrowhead) in splenic artery caused by septic emboli is also observed. Due to retrograde flow with celiac stenosis, gastroepiploic artery 
and splenic artery are visualized on superior mesenteric angiogram. B. Successful N-butyl cyanoacrylate embolization (arrows) was done by 
superselection of bleeding focus at common hepatic artery level.
A B
Fig. 2. Eighty seven-year-old female who previously underwent surgical repair of aortic dissection (patient No. 4). 
A. Right gastroepiploic angiogram shows extravasation (arrows) at greater curvature of stomach near hemoclips (arrowhead). B. Embolization 
with gelfoam slurry and microcoils (arrow) was performed at proximal part of bleeding focus due to marked tortuosity of right gastroepiploic 
artery. Splenic angiogram shows no collateral flow from left gastroepiploic artery (not shown). Although post-embolization angiogram shows no 
further bleeding, patient underwent laparotomy due to uncontrolled bleeding.
A BKorean J Radiol 13(2), Mar/Apr 2012 kjronline.org 179
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147 (1.4%) patients (19, 20), indicating that the rates of 
major bleeding complications are similar after radiologic, 
endoscopic, and surgical gastrostomy. 
Although the incidence of bleeding complications 
following gastrostomy is not high, managing such 
complications is important because of their potentially 
serious consequences, which include death (6, 10, 14). 
Among the available treatment options are conservative 
management, endoscopic hemostasis, TAE, and surgery. 
Conservative management of gastrostomy-related bleeding 
with blood transfusion has been reported (6, 9, 18, 21). 
For example, three of five patients with bleeding recovered 
uneventfully after transfusion (6), and one HIV-seropositive 
(9) with upper GI bleeding following PEG was successfully 
managed by transfusion. Another patient with PEG-
associated upper GI bleeding recovered after a transfusion, 
who presented with focal erythema and a clot at the 
gastrostomy site without active bleeding (21). We found 
that upper GI bleeding in three of our eight patients was 
controlled by transfusion or local compression.
Endoscopic interventions such as sclerotherapy or 
hemoclip placement have been shown effective for 
managing gastrostomy-related upper GI bleeding (11). 
Endoscopy is superior in localizing the bleeding site, 
characterizing the cause of bleeding, and showing the 
relationship between the bleeding site and the gastrostomy 
tube. Endoscopy, however, may be limited by several 
factors, including the presence of comorbid illnesses, 
active bleeding, bleeding vessels larger than 2 mm, 
and endoscopic blind spots, all of which may increase 
hemostatic failure for upper GI bleeding (22, 23). In our 
study, one patient (No. 4) showed persistent bleeding even 
after fibrin glue injection and endoscopic clipping because 
of profuse bleeding from a surgically confirmed gastric 
artery tear. Patients with a failed endoscopic intervention 
should be considered for TAE or surgical treatment. 
TAE is widely accepted for the management of upper GI 
bleeding, especially in patients who fail conservative or 
endoscopic therapy, and is generally preferred over surgery 
in high-risk patients. There have been a few reports about 
TAE treatment for bleeding complications after PEG (8, 10). 
For example, occlusion of both gastroepiploic arteries by 
selective TAE successfully stopped bleeding in a patient 
with unstable hemodynamic status after PEG (8), and 
TAE of the left gastric artery was successful in stopping 
massive bleeding after PEG, although that patient died 
of multi-organ failure despite successful hemostasis (10). 
In contrast, less is known about the use of TAE for major 
bleeding after PRG (13). We found that TAE successfully 
controlled bleeding in three of four patients. In the 
remaining patient (No. 4), who showed persistent bleeding 
after TAE, TAE was possible only in the proximal part of 
the bleeding focus because the microcatheter could not be 
further advanced. The persistent bleeding from the distal 
part of the bleeding focus was finally managed with surgery. 
If both the proximal and distal parts of the bleeding 
focus cannot be securely embolized, there is the potential 
for rebleeding. Generally, surgery is a salvage method 
for patients in whom bleeding cannot be controlled by 
endoscopy and/or angiography. 
Blind or prophylactic TAE, defined as TAE without 
angiographic evidence of bleeding, may be beneficial (24-
27). As massive bleeding is sometimes intermittent (28) 
and TAE in the upper GI tract is generally considered safe, 
blind TAE for upper GI bleeding is recommended when 
guided endoscopically (25-27). Indeed, one of our patients 
(No. 1) with no angiographically determined bleeding focus 
was successfully treated by prophylactic TAE of both gastric 
and right gastroepiploic arteries with gelfoams.
The causes of bleeding after PEG include the direct 
puncture of blood vessels, traumatic erosion of the mucosa, 
and ulceration induced by an internal bolster (29). Among 
the 17 patients who developed upper GI bleeding after PEG, 
reflux esophagitis was the most common cause, followed 
by gastric ulcer and gastric erosions (11). That study found 
that the time from PEG to bleeding was usually more than 3 
days (mean, 308 days). In contrast, we found that the time 
interval between PRG and detection of bleeding was always 
less than 3 days (mean, 33.4 h). A longer time interval 
suggests that bleeding in these patients is due to irritation 
or ulceration by an internal bolster. In both of our patients 
(No. 1, 5) with endoscopically or pathologically determined 
underlying hemorrhagic gastritis or angiodysplasia, mucosal 
irritation or injury induced by tubes or gastrostomy devices 
may have resulted in bleeding after PRG. In one patient (No. 
8) with a small amount of bloody drainage, which ceased 
after compression of the gastrostomy site, anticoagulants 
would have provoked oozing blood from the gastrostomy 
site. Direct puncture of right gastroepiploic artery would 
be the cause of bleeding in one patient (No. 4) as a tear 
of the vessel was confirmed at the operating field. For the 
remaining four patients including two patients (No. 2, 3) 
whose angiography showed extravasation, we suggest that 
a traumatic injury of the vessels could be the cause of Korean J Radiol 13(2), Mar/Apr 2012 kjronline.org 180
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bleeding. 
This study has limitations. First, it is a retrospective 
review without randomization. Second, the number of study 
patients with major bleeding was small; however, they were 
collected from 574 patients who underwent a PRG over a 
10-year period. 
In conclusion, we found that the incidence of upper 
GI bleeding after PRG was 1.4%, which is comparable to 
previous reports. TAE seems to be safe and effective in 
achieving hemostasis for bleeding after PRG, as the next 
step after conservative management. 
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